LD-2 disclosure · 1st Quarter - Amendment
1DAY SOONER ACTION PROJECT
Client
- Description
- advocacy organization supporting medical research
- Location
- Delaware · United States of America
Registrant
- Location
- Fairfax, Virginia, United States of America
Lobbying activities
6 issuesHealth Issues
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI. Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with the HHS and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives
Lobbyistsms JENNY CAROLINE DEBERRY
Covered position (ms JENNY CAROLINE DEBERRY): Senior Legislative Assistant/ Legislative Assistant, Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst/ Campaign Finance Analyst, Federal Election Commission
TargetedSENATE · HOUSE OF REPRESENTATIVES · Defense, Dept of (DOD) · Health & Human Services, Dept of (HHS)
Medical/Disease Research/Clinical Labs
Pandemic and All-Hazards Preparedness and Response Act (PAHPA) and Prescription Drug User Fee Act (PDUFA) and House and Senate FY26 appropriations bills (and report language) to ensure: adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness; prioritization of improved indoor air quality in military and other federal facilities to promote health (additional legislation on this topic: NDAA); FDA reforms including maximized use of AI. Support for Sen. Cassidy's anticipated HEP-C elimination legislation. Support for Sen. Cassidy's anticipated HEP-C elimination legislation (including specifically clinical trial research). Communication with congressional offices re: enabling greater use of human challenge studies. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Discussions with the HHS and DoD to support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives